申请人:Yoshitomi Pharmaceutical Industries, Ltd.
公开号:US04005084A1
公开(公告)日:1977-01-25
Morpholine compounds of the formula: ##STR1## wherein each of R.sup.1 and R.sup.2 is a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, and pharmaceutically acceptable acid addition salts thereof, have strong inhibitory activities on peptic ulcer, gastric motility and gastric secretion but have very weak acetylcholine antagonistic activity.
公式为##STR1##的吗啡啶化合物,其中R.sup.1和R.sup.2中的每一个都是氢原子或具有1至4个碳原子的烷基基团,以及其药学上可接受的酸加盐,具有强烈的抑制胃溃疡、胃动力和胃分泌的活性,但其乙酰胆碱拮抗活性非常弱。